$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
乳腺癌肺转移的五大症状表现
2025-10-19 11:44:20
Check Details
激素受体(HR)阳性乳腺癌研究展望
2025-10-19 11:44:20
Check Details
我国乳腺癌发病提前的原因
2025-10-19 11:44:20
Check Details
晚期乳腺癌患者选择综合治疗
2025-10-19 11:44:20
Check Details
摄入水果蔬菜可预防患乳腺癌
2025-10-19 11:44:20
Check Details
奥拉帕尼的新适应症
2025-10-19 11:44:20
Check Details
靶向药物帕博西林主要治疗哪种类型的乳腺癌?
2025-10-19 11:44:20
Check Details
帕博西尼单药最大的耐受剂量是多少?
2025-10-19 11:44:20
Check Details
乳腺癌服用拉帕替尼治疗之前需不需要进行HER-2基因检测
2025-10-19 11:44:20
Check Details
进展期胃癌服用拉帕替尼联合卡培他滨的疗效
2025-10-19 11:44:20
Check Details
来那替尼可否单独服用治疗HER2阳性乳腺癌?
2025-10-19 11:44:20
Check Details
乳腺癌服用达沙替尼和来曲唑联合治疗可获更长生存期
2025-10-19 11:44:20
Check Details
1
2
...
1640
1641
1642
1643
1644
1645
1646
...
4150
4151
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Alectinib for ALK-Positive Lung Cancer: Efficacy, Side Effects & Clinical Outlook
2
Which Generation TKI Is Repotrectinib? Professional Analysis of Next-Gen ROS1 Inhibitor Classification and Clinical Features
3
Dietary Guide During Goserelin Treatment: Scientific Nutrition Management to Alleviate Side Effects and Improve Quality of Life.
4
CYP26A1 Gene Emerges as New Target for Colorectal Cancer Treatment! Folate Metabolism Research Brings Hope for Immunotherapy.
5
Precision Breakthrough: Inavolisib Redefines Survival in PIK3CA-Mutant Breast Cancer
6
Optimal Regorafenib (Stivarga) Administration Guide: Low-Fat Diet, Fixed Timing, and Dose Escalation Strategies
7
Guidelines for the timing, method, and precautions of taking Erlotinib (Trokai).
8
Important Information for Safe Use of Ibrutinib
9
Comprehensive description of palbociclib
10
Pralsetinib: The RET Precision-Targeted Therapy That Rewrites the Treatment History of Rare Cancers
11
Detailed introduction to the instruction manual of revumenib
12
Ryeqo (Relugolix compound tablets) - long-term treatment for uterine fibroids